Biofrontera AG (ETR:B8FK)
Germany · Delayed Price · Currency is EUR 2.520
+0.030 (1.20%)
Apr 17, 2026, 5:43 PM CET
Biofrontera AG Revenue
In the year 2025, Biofrontera AG had annual revenue of 13.19M EUR, down -39.13%.
Revenue
13.19M
Revenue Growth
-27.43%
P/S Ratio
1.18
Revenue / Employee
173.54K
Employees
76
Market Cap
15.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.19M | -8.48M | -39.13% |
| Dec 31, 2024 | 21.67M | -10.58M | -32.81% |
| Dec 31, 2023 | 32.25M | 6.51M | 25.29% |
| Dec 31, 2022 | 25.74M | -3.05M | -10.59% |
| Dec 31, 2021 | 28.79M | -1.56M | -5.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.58B |
| Siemens Healthineers AG | 23.30B |
| Fresenius SE & Co. KGaA | 22.87B |
| Merck KGaA | 21.10B |
| Maternus-Kliniken Aktiengesellschaft | 116.17M |
| DocCheck AG | 56.60M |
| MeVis Medical Solutions AG | 16.06M |
| Geratherm Medical AG | 14.29M |